Loading clinical trials...
Loading clinical trials...
To evaluate the effect of capacitive and resistive radiofrequency on postpartum rectus abdominis diastasis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cairo University
NCT07536087 · Endoscopic Ultrasound-Guided Radiofrequency Ablation, Pancreatic Neuroendocrine Tumors (pNET), and more
NCT07140757 · Low Risk, Papillary Thyroid Cancer, and more
NCT07389993 · Diastasis Recti Abdominis (DRA)
NCT07272187 · Insulinoma; Pancreas, MEN1, and more
NCT07233616 · Chronic Venous Insufficiency, CVI, Radiofrequency Ablation, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions